Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 17 are a HOLD (3.34%), 492 are a BUY (96.66%).
Analyst Andrew Fein, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 31.67% that have a potential upside of 50.8% achieved within 144 days.
Andrew Fein’s has documented 1,031 price targets and ratings displayed on 57 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 01-Nov-2024.
Analyst best performing recommendations are on SVRA (SAVARA).
The best stock recommendation documented was for SVRA (SAVARA) at 6/12/2019. The price target of $6 was fulfilled within 1 day with a profit of $4.57 (43.24%) receiving and performance score of 432.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
26 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$8.19 (55.30%)
$30
2 months 28 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$27
$12.19 (82.31%)
$27
2 months 28 days ago
(08-Aug-2024)
8/21 (38.1%)
$11.28 (71.76%)
119
Buy
$20
$5.19 (35.04%)
$28
2 months 29 days ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
Buy
$28
$13.19 (89.06%)
$30
2 months 29 days ago
(07-Aug-2024)
0/3 (0%)
$12.83 (84.57%)
Which stock is Andrew Fein is most bullish on?
Which stock is Andrew Fein is most reserved on?
What Year was the first public recommendation made by Andrew Fein?